| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.058 | 0.2 |